Novartis Home
At Novartis, we are reimagining medicine
Environmental, Social and Governance (ESG) Index
Novartis aims to report comprehensively and transparently about ESG topics. We have created the Novartis ESG Index to signpost where our key disclosures can be found across our publications and channels.
Novartis launches Biome India
Novartis announces the launch of the Novartis Biome India, a digital innovation hub aimed at boosting the connection and interaction between Novartis and partners across the digital ecosystem.
Novartis 2019 Financial Results
Novartis announces the company’s fourth quarter and 2019 full year financial results.
Annual Review 2019
The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2019.
Novartis at the World Economic Forum Annual Meeting Davos 2020
Novartis attended the 2020 World Economic Forum Annual Meeting in Davos, with the theme ‘Stakeholders for a Cohesive and Sustainable World’.
Novartis and Microsoft AI collaboration
Novartis and Microsoft announced their collaboration to transform medicine with artificial intelligence.
Accelerating our digital transformation with Amazon Web Services (AWS)
We are collaborating with AWS to build an enterprise-wide data and analytics platform to help transform business operations, starting with the way medicines are manufactured and delivered.
Cell & Gene Therapy at Novartis
We are reimagining medicine to power breakthrough innovation in cell and gene therapy.